Wollina U
Department of Dermatology, University of Jena, 07740 Jena, Germany.
Oncol Rep. 1998 Jan-Feb;5(1):57-9.
Lymphomatoid papulosis (LP) is a rare low-grade T-cell lymphoma which may respond to cytotoxic drugs and PUVA irradiation but long-term remission has not been achieved. Extracorporeal photochemotherapy (ECP) is an immunomodulating therapy used successfully for several types of CTCL, no experience with LP has been reported yet. ECP therapy with 8-methoxypsoralen was introduced on two subsequent days once per month for half a year in a 42-year old women with a 20-year history of LP. Disseminated papules disappeared rapidly after 3 cycles of ECP treatment but metastatic spread continued, which made necessary a subsequent polychemotherapy. One year later, the patient died of central nervous system metastasis. ECP monotherapy seems unable to control disease progression in LP despite beneficial effects on skin lesions.
淋巴瘤样丘疹病(LP)是一种罕见的低度T T 细胞毒性药物和补骨脂素紫外线A光照射(PUVA)治疗可能有效,但尚未实现长期缓解的T细胞淋巴瘤。体外光化学疗法(ECP)是一种免疫调节疗法,已成功用于多种类型的皮肤T细胞淋巴瘤(CTCL),但尚未有LP治疗经验的报道。一名有20年LP病史的42岁女性,每月两次,连续两天使用8-甲氧基补骨脂素进行ECP治疗,持续半年。3个周期的ECP治疗后,播散性丘疹迅速消失,但转移仍在继续,因此随后需要进行多药化疗。一年后,患者死于中枢神经系统转移。尽管ECP对皮肤病变有有益作用,但ECP单一疗法似乎无法控制LP的疾病进展。